Clinical Trials Browser

Phase 2 × nintedanib × NET × Clear all

NCT02399215 2023-12-26

Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Phase 2 Completed

32 enrolled 12 charts

Carcinoid Tumor, Neuroendocrine Tumors